SCHEMBL5206429

SCHEMBL5206429

Nc1ncc(Cc2ccc(C(F)(F)F)cc2Cl)c(N2CCCC(=O)C2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRAP1 Q12931 3/20 0.39
DHFR P00374 3/20 0.39
SMN1; SMN2 Q16637 4/20 0.35
MAPT P10636 3/20 0.35
LMNA P02545 2/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HTT P42858 1/20 0.35
SMO Q99835 1/20 0.34
TP53 P04637 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90B1 P14625 1/20 0.34
CYP3A4 P08684 1/20 0.33
MC4R P32245 1/20 0.33
MC5R P33032 1/20 0.33
MC3R P41968 1/20 0.33
FFAR1 O14842 1/20 0.33
ALOX5AP P20292 1/20 0.33
FEN1 P39748 1/20 0.33
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5202937 0.88 TRAP1 (0.42) TRAP1DHFRSMN1; SMN2MAPTLMNA
SCHEMBL5203846 0.87 SMN1; SMN2 (0.40) DHFRSMN1; SMN2MAPTLMNAALDH1A1
SCHEMBL5207346 0.85 HSP90AA1 (0.36) TRAP1DHFRHSP90AA1HSP90B1FFAR1
SCHEMBL5207721 0.85 TRAP1 (0.36) TRAP1DHFRHSP90AA1HSP90B1
SCHEMBL7163517 0.85 RPS6KB1 (0.40) SMN1; SMN2MAPTALDH1A1HTTSMO
SCHEMBL5206648 0.79 DHFR (0.38) DHFR
SCHEMBL5202556 0.74 DHFR (0.35) DHFR
SCHEMBL5202765 0.74 DHFR (0.38) DHFR
SCHEMBL5202924 0.74 DHFR (0.43) DHFR
SCHEMBL5206883 0.74 DHFR (0.43) TRAP1DHFRSMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP claimed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US claimed
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP disclosed
US-6916820-B1 Neurotrophic substituted pyrimidines KRENITSKY PHARMACEUTICALS, INC. (US) 2005-07-12 US disclosed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US disclosed